New York, NY (1888PressRelease)
April 26, 2009 - American Health Systems Corporation, a leading Drug Safety and Pharmacovigilance CRO, has announced that co-founder Steven Richardson PhD has stepped down as President and CEO. He will serve as Chief Financial Officer and a strategic advisor.
Chief Medical Officer Dr Alan L. Bess will take over Richardson’s responsibilities.
"Dr Bess is the ideal executive to lead American HSC. He has brought a new strategic direction and operational excellence to the company in his role as Chief Medical Officer over the past several months. He has been responsible for the delivery of pharmacovigilance support to several of the world's top pharmaceutical companies, implementing high quality standards, excellent customer service, and outstanding compliance. I know it's time to let him take the reins and guide this great organization” said Dr Richardson. "I've been so honored and humbled to work with American HSC this past year”.
Before joining American HSC, Alan L. Bess, M.D. was Head of Clinical Drug Safety & Epidemiology at Novartis (2000-2008) and Head of Drug Safety at Hoffmann-La Roche (1994-2000).
About American Health Systems Corporation
American HSC is an internationally recognized leader in Drug Safety consulting, offering a full range of integrated services to help develop, implement, and maintain Drug Safety, Pharmacovigilance, and Pharmacoepidemiology programs. Its mission is to offer strategically sound, expertly staffed, and flawlessly executed Drug Safety solutions with an impressive complement of both strategic and tactical support. American HSC delivers a unique combination of highly skilled and experienced drug safety experts, exclusive technology, and best practices in drug safety and pharmacovigilance. To learn more about American HSC please visit their website at www.americanhsc.net, or send an e-mail to info ( @ ) americanhsc dot net
###
